BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 24423239)

  • 1. Aberrant DNA methyltransferase expression in pancreatic ductal adenocarcinoma development and progression.
    Gao J; Wang L; Xu J; Zheng J; Man X; Wu H; Jin J; Wang K; Xiao H; Li S; Li Z
    J Exp Clin Cancer Res; 2013 Nov; 32(1):86. PubMed ID: 24423239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of DNMT1 and DNMT3a are regulated by GLI1 in human pancreatic cancer.
    He S; Wang F; Yang L; Guo C; Wan R; Ke A; Xu L; Hu G; Xu X; Shen J; Wang X
    PLoS One; 2011; 6(11):e27684. PubMed ID: 22110720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of increased DNA methyltransferase expression with carcinogenesis and poor prognosis in pancreatic ductal adenocarcinoma.
    Zhang JJ; Zhu Y; Zhu Y; Wu JL; Liang WB; Zhu R; Xu ZK; Du Q; Miao Y
    Clin Transl Oncol; 2012 Feb; 14(2):116-24. PubMed ID: 22301400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic targeting DNMT1 of pancreatic ductal adenocarcinoma using interstitial control release biodegrading polymer reduced tumor growth through hedgehog pathway inhibition.
    Huang MH; Chou YW; Li MH; Shih TE; Lin SZ; Chuang HM; Chiou TW; Su HL; Harn HJ
    Pharmacol Res; 2019 Jan; 139():50-61. PubMed ID: 30385365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of myofibroblasts in innate chemoresistance of pancreatic carcinoma--epigenetic downregulation of caspases.
    Müerköster SS; Werbing V; Koch D; Sipos B; Ammerpohl O; Kalthoff H; Tsao MS; Fölsch UR; Schäfer H
    Int J Cancer; 2008 Oct; 123(8):1751-60. PubMed ID: 18649362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KIAA1199/CEMIP/HYBID overexpression predicts poor prognosis in pancreatic ductal adenocarcinoma.
    Koga A; Sato N; Kohi S; Yabuki K; Cheng XB; Hisaoka M; Hirata K
    Pancreatology; 2017; 17(1):115-122. PubMed ID: 28012880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PRMT1 promotes pancreatic cancer growth and predicts poor prognosis.
    Song C; Chen T; He L; Ma N; Li JA; Rong YF; Fang Y; Liu M; Xie D; Lou W
    Cell Oncol (Dordr); 2020 Feb; 43(1):51-62. PubMed ID: 31520395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An increased expression of long non-coding RNA PANDAR promotes cell proliferation and inhibits cell apoptosis in pancreatic ductal adenocarcinoma.
    Jiang Y; Feng E; Sun L; Jin W; You Y; Yao Y; Xu Y
    Biomed Pharmacother; 2017 Nov; 95():685-691. PubMed ID: 28886528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulated long noncoding RNA LINC01296 indicates a dismal prognosis for pancreatic ductal adenocarcinoma and promotes cell metastatic properties by affecting EMT.
    Yuan Q; Zhang Y; Feng L; Jiang Y
    J Cell Biochem; 2019 Jan; 120(1):552-561. PubMed ID: 30203487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of DNA methyltransferase-1 and histone deacetylase-1 in pancreatic cancer.
    Wang W; Gao J; Man XH; Li ZS; Gong YF
    Oncol Rep; 2009 Jun; 21(6):1439-47. PubMed ID: 19424621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancer of zeste homolog 2 silences microRNA-218 in human pancreatic ductal adenocarcinoma cells by inducing formation of heterochromatin.
    Li CH; To KF; Tong JH; Xiao Z; Xia T; Lai PB; Chow SC; Zhu YX; Chan SL; Marquez VE; Chen Y
    Gastroenterology; 2013 May; 144(5):1086-1097.e9. PubMed ID: 23395645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HOXB7 mRNA is overexpressed in pancreatic ductal adenocarcinomas and its knockdown induces cell cycle arrest and apoptosis.
    Chile T; Fortes MA; Corrêa-Giannella ML; Brentani HP; Maria DA; Puga RD; de Paula Vde J; Kubrusly MS; Novak EM; Bacchella T; Giorgi RR
    BMC Cancer; 2013 Oct; 13():451. PubMed ID: 24088503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic and Functional Significance of MAP4K5 in Pancreatic Cancer.
    Wang OH; Azizian N; Guo M; Capello M; Deng D; Zang F; Fry J; Katz MH; Fleming JB; Lee JE; Wolff RA; Hanash S; Wang H; Maitra A
    PLoS One; 2016; 11(3):e0152300. PubMed ID: 27023625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased CDC20 expression is associated with pancreatic ductal adenocarcinoma differentiation and progression.
    Chang DZ; Ma Y; Ji B; Liu Y; Hwu P; Abbruzzese JL; Logsdon C; Wang H
    J Hematol Oncol; 2012 Apr; 5():15. PubMed ID: 22475564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RACK1 overexpression associates with pancreatic ductal adenocarcinoma growth and poor prognosis.
    Li X; Xiao Y; Fan S; Xiao M; Wang X; Chen X; Li C; Zong G; Zhou G; Wan C
    Exp Mol Pathol; 2016 Oct; 101(2):176-186. PubMed ID: 27498047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement factor B regulates cellular senescence and is associated with poor prognosis in pancreatic cancer.
    Shimazaki R; Takano S; Satoh M; Takada M; Miyahara Y; Sasaki K; Yoshitomi H; Kagawa S; Furukawa K; Takayashiki T; Kuboki S; Sogawa K; Motohashi S; Nomura F; Miyazaki M; Ohtsuka M
    Cell Oncol (Dordr); 2021 Aug; 44(4):937-950. PubMed ID: 34075561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant expression of a disintegrin and metalloproteinase 17/tumor necrosis factor-alpha converting enzyme increases the malignant potential in human pancreatic ductal adenocarcinoma.
    Ringel J; Jesnowski R; Moniaux N; Lüttges J; Ringel J; Choudhury A; Batra SK; Klöppel G; Löhr M
    Cancer Res; 2006 Sep; 66(18):9045-53. PubMed ID: 16982746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of DNA methyltransferases DNMT1, 3A, and 3B in normal hematopoiesis and in acute and chronic myelogenous leukemia.
    Mizuno S; Chijiwa T; Okamura T; Akashi K; Fukumaki Y; Niho Y; Sasaki H
    Blood; 2001 Mar; 97(5):1172-9. PubMed ID: 11222358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
    Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
    World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA methyltransferase 1/3a overexpression in sporadic breast cancer is associated with reduced expression of estrogen receptor-alpha/breast cancer susceptibility gene 1 and poor prognosis.
    Yu Z; Xiao Q; Zhao L; Ren J; Bai X; Sun M; Wu H; Liu X; Song Z; Yan Y; Mi X; Wang E; Jin F; Wei M
    Mol Carcinog; 2015 Sep; 54(9):707-19. PubMed ID: 24464625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.